Firazyr 30 MG per 3 ML Prefilled Syringe
- RxCUI
- 1148145
- RxNorm name
- Firazyr 30 MG per 3 ML Prefilled Syringe
- Display name
- Firazyr 30 MG per 3 ML Prefilled Syringe
- Full name
- Firazyr 30 MG per 3 ML Prefilled Syringe
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:26
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Firazyr | ICATIBANT ACETATE | Takeda Pharmaceuticals America, Inc. | ed6657ca-ab68-477a-9968-e12dc928b540 | 2025-07-07 | Warnings, Adverse reactions | 1148145 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| ed6657ca-ab68-477a-9968-e12dc928b540 | firazyr 30 MG in 3 ML Prefilled Syringe [PSN] · 3 ML icatibant 10 MG/ML Prefilled Syringe [Firazyr] [SBD] · 3 ML Firazyr 10 MG/ML (as icatibant acetate) Prefilled Syringe [SY] · 3 ML Firazyr 10 MG/ML Prefilled Syringe [SY] · Firazyr 30 MG per 3 ML Prefilled Syringe [SY] | 5 | 19 | These highlights do not include all the information needed to use FIRAZYR ® (icatibant) safely and effectively. See full prescribing information for FIRAZYR. FIRAZYR (icatibant) Injection, for subcutaneous use Initial U.S. Approval: 2011 | 20250707 |